Stocks
LadRx CorporationCYTR
OTCHealthcareBiotechnology$0.09-2.17%
Price as of · delayed, not real-time
Focused on developing novel cancer therapeutics, this biopharmaceutical company specializes in treatments for advanced-stage malignancies. Investors monitor its clinical-stage pipeline, particularly its lead drug candidate targeting drug-resistant tumors, given the high unmet need in oncology. The company's micro-cap status and developmental focus make it a speculative play in the biotech sector.
Market Cap: $052W Range: $0.05-$0.86
Congressional Interest in LadRx Corporation (CYTR)
1 member of Congress has disclosed 1 trade in LadRx Corporation (CYTR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CYTR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-07-31 | Roger W. Marshall | buy | $1K-$15K |